Scientific Poster Download

Scientists constantly experience a lot of challenges during years of discovery process, such as fragmented CRO network, challenging conjugation, and analytical characterization for diversified moieties. Among those faced during discovery efforts for antibody-drug conjugates (ADCs), is the precise control of drug-to-antibody ratio (DAR) and drug distribution. WuXi XDC’s integrated bioconjugate discovery platform, WuXi DAR technology, includes antibody, linker-payload and ADC/bioconjugate preparation, developability assessment, proprietary narrow DAR distribution technology, and in vitro/in vivo characterization to precisely control the conjugate drug load to DAR2, DAR4 or DAR6.

This scientific poster was originally presented during the 2023 World ADC Conference in London